Treating Heart Failure With hPSC-CMs

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Heart failure has a high morbidity and mortality because the heart is one of the least regenerative organs in the human body. Drug treatments for heart failure manage symptoms but do not restore lost myocytes. Cellular replacement therapy is a potential approach to repair damaged myocardial tissue, restore cardiac function, which has become a new strategy for the treatment of heart failure. The purpose of this study is to assess the safety, feasibility and efficacy of intramyocardial delivery of cardiomyocytes at the time of coronary artery bypass grafting in patients with chronic heart failure.
Epistemonikos ID: bbbb27134a55d2aeba887ab328c18267c975addc
First added on: May 21, 2024